Single-Photon Emission Computed Tomography Market

Rapid technological upgradation of C.T. Scan is driving the market growth

Market CAGR for single photon emission computerized tomography (SPECT) is driven by the rapid advancement of C.T. scanners. The development of technologically advanced single photon emission computerized tomography (SPECT) scanners is one of the main factors propelling market progress. The key industry participants are constantly working to create technologically advanced items. The length of hospital stays has been greatly decreased thanks to single photon emission computerized tomography (SPECT) scanners, which have also improved cancer diagnosis. Recent developments in single photon emission computerized tomography (SPECT) scanning technology include reduced patient radiation exposure, accelerated scanning times, and enhanced image quality.

The Global Single-Photon Emission Computed Tomography Market Industry is projected to experience substantial growth in the coming years. With a market value of 1.71 USD Billion in 2024, it is expected to reach 3.56 USD Billion by 2035. This growth trajectory suggests a compound annual growth rate of 6.89% from 2025 to 2035. Such projections indicate a robust demand for SPECT technology driven by various factors, including technological advancements, rising disease prevalence, and increased healthcare investments. The anticipated growth reflects the critical role of SPECT in modern diagnostics, highlighting its importance in improving patient care and outcomes.

The Global Single-Photon Emission Computed Tomography Market Industry is also driven by the increasing geriatric population. As individuals age, they are more susceptible to various health issues, including neurological disorders and cardiovascular diseases, which necessitate advanced diagnostic imaging. SPECT is particularly valuable in evaluating conditions such as Alzheimer's disease and other dementias, providing critical insights into brain function. The demographic shift towards an older population is prompting healthcare providers to adopt SPECT technology more widely. This trend is expected to support market growth, with a compound annual growth rate of 6.89% projected for the period from 2025 to 2035, indicating a robust demand for diagnostic imaging solutions tailored to the elderly.

The Global Single-Photon Emission Computed Tomography Market Industry benefits from the growing awareness of the importance of early diagnosis in disease management. Patients and healthcare providers are increasingly recognizing that early detection can lead to better treatment outcomes and improved quality of life. SPECT imaging provides valuable information that aids in the timely diagnosis of various conditions, including cancers and cardiac diseases. This heightened awareness is driving demand for SPECT technology, as healthcare systems strive to implement more effective diagnostic protocols. Consequently, the market is poised for growth, with the increasing emphasis on preventive healthcare likely to bolster the adoption of SPECT imaging solutions.

The Global Single-Photon Emission Computed Tomography Market Industry is positively impacted by the expansion of healthcare infrastructure, particularly in emerging economies. As these regions invest in modernizing their healthcare facilities, there is a growing need for advanced diagnostic imaging technologies, including SPECT. The establishment of new hospitals and diagnostic centers is creating opportunities for the adoption of SPECT systems, which are essential for accurate disease diagnosis and management. This expansion is expected to drive market growth, as healthcare providers seek to enhance their diagnostic capabilities. The increasing availability of SPECT technology in these regions may lead to improved patient outcomes and greater access to quality healthcare.

The Global Single-Photon Emission Computed Tomography Market Industry is significantly influenced by the rising prevalence of cardiovascular diseases. As these conditions become more common, the demand for effective diagnostic tools increases. SPECT plays a crucial role in assessing myocardial perfusion and detecting coronary artery disease, making it an essential tool in cardiology. With the global burden of cardiovascular diseases expected to rise, healthcare systems are likely to invest more in SPECT technology. This trend is anticipated to contribute to the market's growth, with projections indicating a market value of 3.56 USD Billion by 2035, reflecting a growing recognition of the importance of early diagnosis and intervention.

The Global Single-Photon Emission Computed Tomography Market Industry is experiencing rapid technological advancements that enhance imaging techniques. Innovations such as hybrid imaging systems, which combine SPECT with CT, are becoming increasingly prevalent. These systems provide improved diagnostic accuracy and better anatomical localization of functional abnormalities. As a result, healthcare providers are more inclined to adopt these advanced systems, which are projected to drive market growth. The integration of artificial intelligence in image analysis further augments the capabilities of SPECT, potentially leading to more precise and efficient patient management. Such advancements are likely to contribute to the market's expansion, with a projected value of 1.71 USD Billion in 2024.

By region, the study provides market insights into North America, Europe, Asia-Pacific and Rest of the World. The North American single-photon emission computed tomography market area will dominate this market. One of the main factors influencing the market's expansion is the healthcare industry's quick adoption of modern imaging technology in North America. The region's SPECT market is expanding due to more and more radiopharmaceutical devices for computed imaging being discovered. Demand for efficient molecular imaging SPECT scanners has increased recently due to an increase in cancer and cardiovascular disease cases.

Further, the major countries studied in the market report are US, Canada, France, German, Italy, UK, Spain, Japan, China, Australia, India, South Korea, and Brazil.

Figure 2  SINGLE PHOTON EMISSION COMPUTERISED TOMOGRAPHY (SPECT)MARKET SHARE BY REGION 2022 (USD Billion)

Source Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe’s single-photon emission computed tomography market accounts for the second-largest market share due to rising chronic disease awareness, well-established healthcare facilities in Germany, France, and Italy, and rising demand from these facilities for modern healthcare systems. Further, the German single-photon emission computed tomography market held the major market share, and the UK single-photon emission computed tomography market was the rapidly growing market in the European region.

The Asia-Pacific Single-Photon Emission Computed Tomography Market is expected to expand at a rapid rate from 2023 to 2032. Due to the region's rapidly expanding economies, particularly those of China and India, and the region's expanding healthcare infrastructure, the market for single photon emission computerized tomography (SPECT) is expected to grow at a strong CAGR in Asia Pacific throughout the forecast period. Additionally, expanding local producers and the rising frequency of chronic diseases are anticipated to support market expansion.

Moreover, China’s single-photon emission computed tomography market held the largest market share, and the Indian single-photon emission computed tomography market was the rapidly growing market in the Asia-Pacific region.

Leading market players are largely investing in research and development to expand their product lines, which will help the single photon emission computerized tomography (SPECT) grow even more. The launch of new products, larger-scale mergers and acquisitions, contractual agreements, and collaboration with other organizations are significant market developments in which market participants engage to increase their  presence. The single-photon emission computed tomography industry must provide affordable products to expand and thrive in a more competitive and challenging market environment.

One of the major business strategies manufacturers use in the  single-photon emission computed tomography industry to increase the market sector and benefits customers is local manufacturing to lower operational costs. In recent years, the single-photon emission computed tomography industry has stipulated some of the most important medicinal benefits.  Major players in the single-photon emission computed tomography industry, including Siemens Healthcare, Koninklijke Philips N.V., Mediso Ltd., Spectrum Dynamics Medical, GE Healthcare, and others, are funding operations for research and development to boost market demand.

Spectrum Dynamics creates nuclear imaging technologies for medical applications for patients and clinicians. Hand-held nuclear imaging instruments for cancer diagnosis, CZT detectors for SPECT imaging, and other nuclear medicine applications are available in the United States, Europe, Japan, and other markets. In October 2022, Spectrum Dynamics revealed its most recent advancement in digital nuclear medicine imaging the capacity to image high energy isotopes employing solid-state detector technology in a 3600 -CZT-based, wide-bore SPECT/CT configuration. This capability is included in the new VERITON-CT 400 Series Digital SPECT/CT scanners, allowing for total body, brain, heart, and other imaging applications.

Siemens Healthineers AG (Siemens Healthineers) is a medical technology firm that designs, develops, manufactures, and distributes diagnostic imaging systems, clinical and workflow systems and solutions, and systems for minimally invasive treatments. The company's main products include molecular imaging systems, X-ray products, computed tomography systems, magnetic resonance imaging systems, and testing systems. In June 2022, Siemens Healthineers received FDA approval for the Symbia Pro. It is a single-photon emission computed tomography/computed tomography (SPECT/CT) system combining advanced CT and SPECT imaging technologies.

Among the capabilities are a low-dose CT with up to 64 slices for outstanding detail, automatic SPECT motion correction for further picture clarity, and a simple and automated workflow to guide the user through the full examination decision-making process.